Long Term Open Label Treatment with Inhaled Treprostinil for Pulmonary Arterial Hypertension

被引：0
|
作者：
Voswinckel, R. [1 ]
van Dijk, J. [2 ]
Edelmann, R. [1 ]
Gall, H. [1 ]
Channick, R. [2 ]
Olschewski, H. [3 ]
Ghofrani, H. A. [1 ]
Seeger, W. [1 ]
Rubin, L. J. [2 ]
机构：
[1] Univ Giessen, Lung Ctr, D-35390 Giessen, Hesse, Germany
[2] UCSD, La Jolla, CA USA
[3] Univ Hosp Graz, Graz, Austria
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3352
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Experiences with treprostinil in the treatment of pulmonary arterial hypertension
    Stream, Amanda R.
    Bull, Todd M.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (05) : 269 - 276
  • [32] Oral treprostinil in the treatment of pulmonary arterial hypertension
    Feldman, Jeremy
    Habib, Naomi
    Radosevich, John
    Dutt, Mohan
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1661 - 1667
  • [33] Long-term continuous subcutaneous treprostinil therapy for pulmonary arterial hypertension
    Skoro-Sajer, N
    Harja, E
    Bonderman, D
    Rezaie-Majd, S
    Machherndl, S
    Kneussl, M
    Lang, MI
    EUROPEAN HEART JOURNAL, 2003, 24 : 483 - 483
  • [34] Long-term experience with implantable treprostinil pumps in pulmonary arterial hypertension
    Dytrych, V
    Kuchar, J.
    Ambroz, D.
    Kunstyr, J.
    Grus, T.
    Lindner, J.
    Linhart, A.
    Jansa, P.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (05): : 358 - 361
  • [35] Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Bourge, Robert C.
    Tapson, Victor F.
    Safdar, Zeenat
    Benza, Raymond L.
    Channick, Richard N.
    Rosenzweig, Erika B.
    Shapiro, Shelley
    White, Richard James
    McSwain, Christopher Shane
    Gotzkowsky, Stephen Karl
    Nelsen, Andrew C.
    Rubin, Lewis J.
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (01) : 38 - 44
  • [36] Oral Selexipag versus Inhaled Treprostinil Effect on Pulmonary Arterial Hypertension
    Nguyen, J. Q.
    Teklu, Y.
    Wu, S.
    Kolaitis, N. A.
    De Marco, T.
    Fanous, S. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S427 - S427
  • [37] Inhaled treprostinil sodium for pulmonary hypertension
    Gupta, Vedant
    Krasuski, Richard A.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (03): : 283 - 291
  • [38] Inhaled treprostinil for treatment of chronic pulmonary arterial hypertension (vol 144, pg 149, 2006)
    Voswinckel, R.
    Ghofrani, H. A.
    Grimminger, F.
    Seeger, W.
    Olschewski, H.
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (11) : 863 - 863
  • [39] The prostacyclin analogue treprostinil in the treatment of pulmonary arterial hypertension
    Pedersen, Mia Lindegaard
    Krueger, Marcus
    Grimm, Daniela
    Infanger, Manfred
    Wehland, Markus
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 (01) : 32 - 42
  • [40] Safety And Tolerability Of Outpatient Transition Of Parenteral And Inhaled Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension
    Khan, A. A.
    Ackerbauer, K.
    Tandon, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
12345